Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glucose lowering by continuous tube feeding and vildagliptin in addition to insulin in hyperglycemic acute stroke patients
2008-007020-25Phase 3Terminated
- Sponsor
- AMC Health
- Start
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of vildagliptin in hyperglycemia and ischemic stroke, sponsored by AMC Health. Primary endpoint: mean glucose. Started Dec 2008; status: terminated.
02
Drugs
vildagliptin
03
Conditions
hyperglycemiaischemic stroke
Beyond the preview
Go deeper on 2008-007020-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-007020-25.